Homozygous Deletion of Glycogen Synthase Kinase 3 Beta Bypasses Senescence Allowing Ras Transformation of Primary Murine Fibroblasts

Shuying Liu,Xianjun Fang,Hassan Hall,Shuangxing Yu,Debra Smith,Zhimin Lu,Dexing Fang,Jinsong Liu,L. Clifton Stephens,James R. Woodgett,Gordon B. Mills

DOI: https://doi.org/10.1073/pnas.0704242105

2008-01-01

Abstract:In primary mammalian cells, expression of oncogenes such as activated Ras induces premature senescence rather than transformation. We show that homozygous deletion of glycogen synthase kinase (GSK) 3 beta (GSK3 beta(-/-)) bypasses senescence induced by mutant Ras(V12) allowing primary mouse embryo fibroblasts (MEFs) as well as immortalized MEFs to exhibit a transformed phenotype in vitro and in vivo. Both catalytic activity and Axin-binding of GSK3 beta are required to optimally suppress Ras transformation. The expression of Ras(V12) in GSK3 beta(-/-), but not in GSK3 beta(+/+) MEFs results in translocation of beta-catenin to the nucleus with concomitant up-regulation of cyclin D1. siRNA-mediated knockdown of beta-catenin decreases both cyclin D1 expression and anchorage-independent growth of transformed cells indicating a causal role for beta-catenin. Thus Ras(V12) and the lack of GSK3 beta act in concert to activate the beta-catenin pathway, which may underlie the bypass of senescence and tumorigenic transformation by Ras.